Publication:
Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma

dc.contributor.authorsTas, Faruk; Atsu, Nilhan
dc.date.accessioned2022-03-12T20:27:49Z
dc.date.accessioned2026-01-11T05:57:40Z
dc.date.available2022-03-12T20:27:49Z
dc.date.issued2016
dc.description.abstractInterferon-alpha is one of the major immune modulating agents used in current oncology practice, including melanoma. We present a case of psoriasis exacerbation induced by INF- in a patient with melanoma.
dc.identifier.doi10.3109/15569527.2015.1020545
dc.identifier.eissn1556-9535
dc.identifier.issn1556-9527
dc.identifier.pubmed25799214
dc.identifier.urihttps://hdl.handle.net/11424/233785
dc.identifier.wosWOS:000368640700015
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofCUTANEOUS AND OCULAR TOXICOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectExacerbation
dc.subjectinterferon
dc.subjectmelanoma
dc.subjectpsoriasis
dc.titleExacerbation of psoriasis induced by interferon-alpha treatment for melanoma
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage84
oaire.citation.issue1
oaire.citation.startPage83
oaire.citation.titleCUTANEOUS AND OCULAR TOXICOLOGY
oaire.citation.volume35

Files